US approves new drug for common skin cancer
 |
| Erivedge (vismodegib) is made by Genentech, a US subsidiary of the Swiss drug giant Roche |
US authorities on Monday approved a new drug to treat the most common form of skin cancer, basal cell carcinoma, which is rarely lethal but can spread if left untreated. read more..
source:http://yhoo.it/wUFGby
No comments:
Post a Comment